Clinical Trials Sponsored by Candler Hospital
Total 128188 results
-
Henan Cancer HospitalRecruitingMRI | Neoadjuvant Therapy | Gastric Cancer Stage | CTChina
-
Henan Cancer HospitalRecruitingEsophageal Cancer | Squamous Cell Carcinoma | Perioperative PeriodChina
-
Zhejiang Cancer HospitalRecruitingHead and Neck NeoplasmsChina
-
Henan Cancer HospitalRecruitingMagnetic Resonance Imaging | Prognosis | Esophageal Cancer TNM StagingChina
-
Henan Cancer HospitalCompletedTriple Negative Breast CancerChina
-
Henan Cancer HospitalActive, not recruiting
-
Hubei Cancer HospitalEnrolling by invitation
-
Zhejiang Cancer HospitalCompletedHypoxia | Propofol | Sedation Complication | Desaturation of BloodChina
-
Zhejiang Cancer HospitalActive, not recruitingEpithelial Ovarian CancerChina
-
Zhejiang Cancer HospitalCompleted
-
Zhejiang Cancer HospitalCompletedOvarian Neoplasm Epithelial
-
Hunan Cancer HospitalCompletedMetastatic Colorectal AdenocarcinomaChina
-
Hunan Cancer HospitalCompleted
-
Fujian Cancer HospitalActive, not recruiting
-
Hunan Cancer HospitalCompletedAnti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal CancerMetastatic Colorectal AdenocarcinomaChina
-
Hunan Cancer HospitalCompletedMetastatic Colorectal AdenocarcinomaChina
-
Barretos Cancer HospitalCompleted
-
Barretos Cancer HospitalCompletedBRCA1 Hereditary Breast and Ovarian Cancer SyndromeBrazil
-
Zhejiang Cancer HospitalCompleted
-
Henan Cancer HospitalActive, not recruitingEsophageal Squamous Cell CarcinomaChina
-
Zhejiang Cancer HospitalCompletedUterine Cervical NeoplasmsChina
-
Hubei Cancer HospitalCompletedNasopharyngeal CarcinomaChina
-
Hubei Cancer HospitalEnrolling by invitation
-
Henan Cancer HospitalActive, not recruiting
-
Zhejiang Cancer HospitalActive, not recruitingEsophageal Squamous Cell CarcinomaChina
-
Zhejiang Cancer HospitalCompletedBreast Cancer | PI3K/AKT/mTOR Pathway Mutation | EverolimusChina
-
Zhejiang Cancer HospitalUnknownAngioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Fujian Cancer HospitalCompleted
-
Fujian Cancer HospitalWithdrawnMetastatic Colorectal CancerChina
-
Zhejiang Cancer HospitalUnknown
-
Henan Cancer HospitalUnknownAdvanced NSCLC With EGFR MutationChina
-
Barretos Cancer HospitalCompletedKidney Cancer | Biomarkers | Gene ExpressionBrazil
-
Henan Cancer HospitalTerminated
-
Zhejiang Cancer HospitalUnknownEvaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast CancerChina
-
Hunan Cancer HospitalUnknown
-
Henan Cancer HospitalUnknownTriple-negative Breast Cancer
-
Zhejiang Cancer HospitalUnknownMetastatic Renal Cell CarcinomaChina
-
Barretos Cancer HospitalUnknown
-
Henan Cancer HospitalUnknownAdvanced Cancer | Mucosal Melanoma | Apatinib | SHR-1210China
-
Henan Cancer HospitalUnknownGastrointestinal Neuroendocrine Tumor
-
Henan Cancer HospitalUnknownAdvanced Gastric Cancer
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownMalignant Neoplasm of NasopharynxChina
-
Fujian Cancer HospitalUnknown
-
Zhejiang Cancer HospitalUnknownNasopharyngeal CarcinomaChina
-
Zhejiang Cancer HospitalUnknown
-
Fujian Cancer HospitalUnknownNon-squamous Non-small Cell Lung Cancer